Drugs / DU125530
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT01119430 Comparator | May 2004 → Nov 2007 | major depressive disorder | Sant Pau Research Institute | Terminated | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DU-125530 | “Preclinical and clinical characterization of the selective 5-HT(1A) receptor antagonist DU-125530 for antidepressant treatment.” PMID 22050051 ↗ Nov 2012 |
| Action | Inhibit | “DU-125530 is an excellent pre- and post-synaptic 5-HT(1A) receptor antagonist.” PMID 22050051 ↗ Nov 20121“Serotonin 1a (5-HT1a) receptor antagonist” CHEMBL79261 ↗ |
| Modality | Small molecule | — CHEMBL79261 ↗ |
| Target | HTR1A | “Serotonin 1a (5-HT1a) receptor antagonist” CHEMBL79261 ↗ |